(a)Since more patients on pioglitazone had cardiovascular problems (5386 vs. 2593) we can conclude that the rate of cardiovascular problems for those on a pigolitazone treatment is higher.
# Cardiovascular problems
# Yes No total
#Treatment Rosiglitazone 2593 65000 67593
# Pioglitazone 5386 154592 159978
# Total 7979 219592 227571
#Rosiglitazone
2593/67593
## [1] 0.03836196
#Pioglitazone
5386/159978
## [1] 0.03366713
0.03836196-0.03366713
## [1] 0.00469483
Since the total number of data samples for those who take Rosiglitazone or Pioglitazone have different total, the first clause of the sentence is wrong assumption, thereby sentence (a) is incorrect.
Difference in the rate of cardiovascular problem of Rosiglitazone and Pioglitazone is 0.00469483.
True
True
Each data sample for different kinds of treatment is independent, so the rates of incidence is not due to a relationship between the two variables; therefore the statement (b) is incorrect.
# Heart transplant
# Group
# Control Treatment total
#Outcome Alive 4 24 28
# Dead 30 45 75
# Total 34 69 103
30 and 45, respectively.
H0; No significant difference in group whether they alive or dead group. H1; There is a significant difference in group.
There is no significant difference in group.
# Sinusitis and antibiotics
# Self reported improvememnt in symptons
# Yes No total
#Treatment ANTIBIOTIC 66 19 85
# PLACEBO 65 16 81
# TOTAL 131 35 166
19/85
## [1] 0.2235294
16/81
## [1] 0.1975309
0.2235294-0.1975309
## [1] 0.0259985
0.0259985
## [1] 0.0259985
There is no significant difference in Antibiotic and Placebo. There is a significant difference in treatment.
We can conclude that given p-value, we can reject that there is a significant difference of effectiveness between antibiotic versus placebo.